双向免疫调节剂-京生·脾氨肽口服溶液：打破过敏性鼻炎合并腺样体肥大的恶性循环，守护儿童自由呼吸

Core Insights - Allergic rhinitis combined with adenoid hypertrophy in children is a growing concern, affecting respiratory quality and potentially leading to various developmental issues [1][2] - The product Jing Sheng Peptide Oral Solution is gaining attention for its dual immune regulation mechanism, which significantly alleviates symptoms and interrupts the disease's vicious cycle [1][3] Group 1: Disease Overview - Allergic rhinitis is one of the most common diseases in children, with a rising global incidence [2] - The adenoid, located in the nasopharynx, can become pathologically enlarged due to allergic reactions, leading to nasal obstruction and symptoms such as nasal congestion, runny nose, snoring, and mouth breathing [2] - The interplay between allergic rhinitis and adenoid hypertrophy can create a vicious cycle, worsening symptoms and impacting children's quality of life, growth, and mental health [2] Group 2: Treatment Mechanism - Traditional treatments for allergic rhinitis and adenoid hypertrophy have limitations, making immune therapy a promising alternative [3] - Jing Sheng Peptide Oral Solution enhances T lymphocyte activity, promotes the secretion of cytokines like IL-2 and gamma-interferon, and activates macrophages, improving various immunoglobulin levels [3] - The solution also helps to rebalance Th1/Th2 immune responses by inhibiting the secretion of IL-4 and IL-5, thus reducing allergic reactions in children [3] Group 3: Clinical Evidence - Multiple studies, including a randomized controlled trial led by Professor Xu Zhengmin from Fudan University, have validated the efficacy and safety of Jing Sheng Peptide Oral Solution [4] - After 8 weeks of treatment, children showed significant reductions in adenoid size and improvements in symptoms such as mouth breathing, sleep disturbances, nasal congestion, and sneezing [4] - The safety profile of the solution is robust, with no abnormal safety indicators reported in clinical studies, attributed to its formulation from healthy bovine spleen without hormones or dependency issues [4] Group 4: Future Outlook - The ongoing development in the field of immune regulation is expected to benefit more children, promoting healthier growth [5] - There is a call for increased awareness among parents and society regarding children's immune health to create a better environment for their development [5]